These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9195606)

  • 1. Glutamatergic control over brain dopamine release in vivo and in vitro.
    Whitton PS
    Neurosci Biobehav Rev; 1997 Jul; 21(4):481-8. PubMed ID: 9195606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine-glutamate reciprocal modulation of release and motor responses in the rat caudate-putamen and nucleus accumbens of "intact" animals.
    David HN; Ansseau M; Abraini JH
    Brain Res Brain Res Rev; 2005 Dec; 50(2):336-60. PubMed ID: 16278019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo presynaptic control of dopamine release in the cat caudate nucleus--II. Facilitatory or inhibitory influence of L-glutamate.
    Chéramy A; Romo R; Godeheu G; Baruch P; Glowinski J
    Neuroscience; 1986 Dec; 19(4):1081-90. PubMed ID: 2881227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional interactions between somatodendritic dopamine release, glutamate receptors and brain-derived neurotrophic factor expression in mesencephalic structures of the brain.
    Bustos G; Abarca J; Campusano J; Bustos V; Noriega V; Aliaga E
    Brain Res Brain Res Rev; 2004 Dec; 47(1-3):126-44. PubMed ID: 15572168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reciprocal dopamine-glutamate modulation of release in the basal ganglia.
    Morari M; Marti M; Sbrenna S; Fuxe K; Bianchi C; Beani L
    Neurochem Int; 1998 Nov; 33(5):383-97. PubMed ID: 9874089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A vitamin as neuromodulator: ascorbate release into the extracellular fluid of the brain regulates dopaminergic and glutamatergic transmission.
    Rebec GV; Pierce RC
    Prog Neurobiol; 1994 Aug; 43(6):537-65. PubMed ID: 7816935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory glutamatergic regulation of evoked dopamine release in striatum.
    Wu Y; Pearl SM; Zigmond MJ; Michael AC
    Neuroscience; 2000; 96(1):65-72. PubMed ID: 10683411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia.
    Grace AA
    Neuroscience; 1991; 41(1):1-24. PubMed ID: 1676137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of glutamate and its receptors in mesocorticolimbic dopaminergic regions in opioid addiction.
    Guo Y; Wang HL; Xiang XH; Zhao Y
    Neurosci Biobehav Rev; 2009 Jun; 33(6):864-73. PubMed ID: 19428497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine release in the nucleus accumbens and latent inhibition in the rat following microinjections of a 5-HT1B agonist into the dorsal subiculum: implications for schizophrenia.
    Boulenguez P; Peters SL; Mitchell SN; Chauveau J; Gray JA; Joseph MH
    J Psychopharmacol; 1998; 12(3):258-67. PubMed ID: 10958252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine and glutamate dysfunctions in schizophrenia: role of the dopamine D3 receptor.
    Leriche L; Diaz J; Sokoloff P
    Neurotox Res; 2004; 6(1):63-71. PubMed ID: 15184107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. alpha-bungarotoxin-sensitive nicotinic receptors indirectly modulate [(3)H]dopamine release in rat striatal slices via glutamate release.
    Kaiser S; Wonnacott S
    Mol Pharmacol; 2000 Aug; 58(2):312-8. PubMed ID: 10908298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of dopamine and noradrenaline release and of intracellular Ca2+ concentration by presynaptic glutamate receptors in hippocampus.
    Malva JO; Carvalho AP; Carvalho CM
    Br J Pharmacol; 1994 Dec; 113(4):1439-47. PubMed ID: 7534187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glutamatergic-dopaminergic balance in the brain. Its importance in motor disorders and schizophrenia.
    Riederer P; Lange KW; Kornhuber J; Danielczyk W
    Arzneimittelforschung; 1992 Feb; 42(2A):265-8. PubMed ID: 1350197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychiatric drugs. Excited by glutamate.
    Holden C
    Science; 2003 Jun; 300(5627):1866-8. PubMed ID: 12817119
    [No Abstract]   [Full Text] [Related]  

  • 16. Voltammetric study of the control of striatal dopamine release by glutamate.
    Borland LM; Michael AC
    J Neurochem; 2004 Oct; 91(1):220-9. PubMed ID: 15379902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutamatergic regulation of basal and stimulus-activated dopamine release in the prefrontal cortex.
    Takahata R; Moghaddam B
    J Neurochem; 1998 Oct; 71(4):1443-9. PubMed ID: 9751176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feeding-evoked dopamine release in the nucleus, accumbens: regulation by glutamatergic mechanisms.
    Taber MT; Fibiger HC
    Neuroscience; 1997 Feb; 76(4):1105-12. PubMed ID: 9027870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine release in the prefrontal cortex during stress is reduced by the local activation of glutamate receptors.
    Del Arco A; Mora F
    Brain Res Bull; 2001 Sep; 56(2):125-30. PubMed ID: 11704349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A model of dopamine modulated glutamatergic synapse.
    Di Maio V; Ventriglia F; Santillo S
    Biosystems; 2015 Oct; 136():59-65. PubMed ID: 26001676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.